201 related articles for article (PubMed ID: 18273576)
1. Oral anticoagulation after myocardial infarction.
Hurlen M; Arnesen H
Herz; 2008 Feb; 33(1):38-43. PubMed ID: 18273576
[TBL] [Abstract][Full Text] [Related]
2. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
[TBL] [Abstract][Full Text] [Related]
3. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
Connolly SJ; Pogue J; Eikelboom J; Flaker G; Commerford P; Franzosi MG; Healey JS; Yusuf S;
Circulation; 2008 Nov; 118(20):2029-37. PubMed ID: 18955670
[TBL] [Abstract][Full Text] [Related]
4. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
[TBL] [Abstract][Full Text] [Related]
5. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
Reikvam A; Madsen S; Landmark K
Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
[TBL] [Abstract][Full Text] [Related]
6. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
van den Bergh PJ; Kievit PC; Brouwer MA; Aengevaeren WR; Veen G; Verheugt FW
Am Heart J; 2009 Mar; 157(3):532-40. PubMed ID: 19249425
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of chronic oral anticoagulation with warfarin after acute myocardial infarction.
Haq SA; Heitner JF; Sacchi TJ; Brener SJ
Am J Med; 2010 Mar; 123(3):250-8. PubMed ID: 20193834
[TBL] [Abstract][Full Text] [Related]
8. [Factors influencing activity of oral anticoagulants. Interactions with drugs and food].
Sawicka-Powierza J; Rogowska-Szadkowska D; Ołtarzewska AM; Chlabicz S
Pol Merkur Lekarski; 2008 May; 24(143):458-62. PubMed ID: 18634396
[TBL] [Abstract][Full Text] [Related]
9. [Oral anticoagulants combined with aspirin in the prolonged treatment after acute coronary syndrome].
Di Pasquale G; Biancoli S; Cerè E; Parlangeli R
Ital Heart J Suppl; 2002 May; 3(5):495-501. PubMed ID: 12064188
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and warfarin versus aspirin monotherapy after myocardial infarction.
Jeddy AS; Gleason BL
Ann Pharmacother; 2003 Oct; 37(10):1502-5. PubMed ID: 14519047
[TBL] [Abstract][Full Text] [Related]
11. Less benefit from warfarin in diabetics after myocardial infarction?
Smith PJ; Hurlen M; Abdelnoor M; Arnesen H
Cardiology; 2008; 111(3):161-6. PubMed ID: 18434719
[TBL] [Abstract][Full Text] [Related]
12. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
[TBL] [Abstract][Full Text] [Related]
13. Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.
Hurlen M; Eikvar L; Seljeflot I; Arnesen H
Thromb Res; 2006; 118(4):433-8. PubMed ID: 16139331
[TBL] [Abstract][Full Text] [Related]
14. Oral anticoagulation after myocardial infarction.
Arnesen H
Thromb Res; 2003 Feb; 109(4):163-70. PubMed ID: 12757769
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
Sarafoff N; Ndrepepa G; Mehilli J; Dörrler K; Schulz S; Iijima R; Byrne R; Schömig A; Kastrati A
J Intern Med; 2008 Nov; 264(5):472-80. PubMed ID: 18624903
[TBL] [Abstract][Full Text] [Related]
16. Long-term anticoagulation in patients with coronary disease, and future developments.
Verheugt FW
Curr Opin Cardiol; 2008 Jul; 23(4):315-9. PubMed ID: 18520714
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of aspirin combined with warfarin after acute coronary syndrome : A meta-analysis.
Zhang P; Li J; Wu C; Huang X; Li L; Zhang W; Shen C
Herz; 2017 May; 42(3):295-306. PubMed ID: 27785526
[TBL] [Abstract][Full Text] [Related]
18. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
[TBL] [Abstract][Full Text] [Related]
19. Risk of major haemorrhage in patients after infrainguinal venous bypass surgery: therapeutic consequences? The Dutch BOA (Bypass Oral Anticoagulants or Aspirin) Study.
Ariesen MJ; Tangelder MJ; Lawson JA; Eikelboom BC; Grobbee DE; Algra A;
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):154-9. PubMed ID: 15996602
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
Anand SS; Yusuf S
JAMA; 1999 Dec; 282(21):2058-67. PubMed ID: 10591389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
